IMVT - Company ID 0001764013
As of 2026-07-09, Immunovant, Inc. (IMVT) has a market capitalization of $8.44 B, making it the #1062 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-07-09 | $8.44 B |
| 2026-07-08 | $8.23 B |
| 2026-07-07 | $8.31 B |
| 2026-07-06 | $7.92 B |
| 2026-07-05 | $7.96 B |
| 2026-07-04 | $7.96 B |
| 2026-07-03 | $7.96 B |
| 2026-07-02 | $7.96 B |
| 2026-07-01 | $7.82 B |
| 2026-06-30 | $7.91 B |
| 2026-06-29 | $7.91 B |
| 2026-06-28 | $7.98 B |
As of 2026-07-09, Immunovant, Inc. (IMVT) has a market capitalization of $8.44 B, making it the #1062 most valuable US-listed company.
Immunovant, Inc. is the #1062 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-06-27 | $7.98 B |
| 2026-06-26 | $7.98 B |
| 2026-06-25 | $7.85 B |
| 2026-06-24 | $7.93 B |
| 2026-06-23 | $7.72 B |
| 2026-06-22 | $7.82 B |
| 2026-06-21 | $7.26 B |
| 2026-06-20 | $7.26 B |
| 2026-06-19 | $7.26 B |
| 2026-06-18 | $7.14 B |
| 2026-06-17 | $7.10 B |
| 2026-06-16 | $6.84 B |
| 2026-06-15 | $6.96 B |
| 2026-06-14 | $6.90 B |
| 2026-06-13 | $6.90 B |
| 2026-06-12 | $6.90 B |
| 2026-06-11 | $6.66 B |
| 2026-06-10 | $6.40 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.